RxDoctor Payments Data

Nitika Thawani, MD

Radiation Oncology · Phoenix, AZNPI 1275728933

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Elekta, Inc. at 43.3% of the total. That places this record below the midpoint for radiation oncology clinicians in AZ, where the typical reported total is $1,482.

$1,240in general payments, 2019–2025

Across 13 payments — averaging $95.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elekta, Inc.$537
  • Novocure Inc.$167
  • Intuitive Surgical$159
  • Siemens Medical Solutions USA, Inc.$140
  • Sanofi$94
  • AstraZeneca$90
  • plus $53 from 2 others
$198,214in research payments, 2019–2025

Across 17 payments — averaging $11,660 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$150K
  • Novocure Inc.$48K

What the payments were for

  • Food & beverage$1,240100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,240 in reported general payments places this provider in the 45th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona

Medicare billing

Part B allowed, 2024
$101,737
Medicare patients
136
Services billed
934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine Hcl ViscousLidocaine Hcl12$98

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →